From evidence to action
At ICARS, our mission is to partner with low- and middle-income countries (LMICs) in their efforts to reduce drug-resistant infections.
We do this by co-developing tailored solutions with LMIC governments and researchers, who then implement them on the ground using ICARS funding and expertise, building on AMR National Action Plans.
Follow us and view our latest news
ICARS Strategy 2022 – 2026
Guided by our vision of a world without drug-resistant infections, we have developed a new strategy with a revised outcome framework and refined the scope and goals of each of our interconnected pillars.
We are pleased to present a succinct overview of ICARS unique value proposition, followed by our overarching strategy that will run until 2026, as well as a roadmap that details our planned activities per pillar.
Our projects inform policy and practice around the world
At ICARS, we simultaneously use top-down and bottom-up approaches, engaging with government ministries while involving scientists and practitioners throughout the process.
Reducing antimicrobial use through improved provision of colostrum and use of vaccines in weaning pigs in Colombia
Reducing weaning diarrhoea and antimicrobial use through improved provision of colostrum and use of vaccines in weaning pigs in Colombia.
Mitigating the spread of antimicrobials and resistant microbes through treatment of manure
This project intends to introduce manure processing technology that will aid in treating manure in Tanzania, leading to safer fertiliser for organic and non-organic products and ultimately safer food products.
Join our mission
To achieve sustainable change in LMICs, we invite countries and foundations to join us as Strategic Funding Partners, Funding Partners or Mission Partners, in a truly international effort to mitigate antimicrobial resistance.
Please do not hesitate to contact our team for further information.